Training scientists in human immunology to improve clinical outcomes
Human and Translational Immunology Training Program
This program is all about helping scientists learn how to better understand the human immune system so they can turn lab discoveries into real treatments for patients, using advanced tools to study how our bodies respond to different diseases.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10890090 on NIH RePORTER |
What this research studies
This program focuses on training scientists in the field of translational immunology, which is essential for bridging the gap between laboratory discoveries and clinical applications. It emphasizes the importance of studying human immune responses, as they differ significantly from those observed in animal models. The training includes advanced methodologies such as genomics and metabolomics to analyze human data, addressing the complexities of immune responses in various diseases. By equipping scientists with these skills, the program aims to enhance our understanding of immune mechanisms and improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with immune system disorders or those affected by diseases where immune modulation is being explored.
Not a fit: Patients with conditions unrelated to immune responses or those not involved in the training of translational immunologists may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients with immune-related diseases.
How similar studies have performed: Previous research in translational immunology has shown promise in improving patient outcomes, indicating that this approach is both relevant and necessary.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Herold, Kevan C — Yale University
- Study coordinator: Herold, Kevan C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.